Showing 2601-2610 of 23150 results for "".
Preventing Allergic Reactions to Peanuts with a Cancer Drug
https://reachmd.com/programs/clinicians-roundtable/preventing-allergic-reactions-to-peanuts-with-a-cancer-drug/18012/Can a blood cancer drug potentially prevent allergic reactions to peanuts? Tune in to find out.Recognizing and Addressing Burnout Among GI Providers
https://reachmd.com/programs/gi-insights/recognizing-and-addressing-burnout-among-gi-providers/26914/Here’s what you should know about recognizing and treating burnout, particularly in gastrointestinal healthcare.Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
https://reachmd.com/programs/frontlines-multiple-sclerosis/managing-ms-in-older-adults-key-considerations-for-dmts-and-lifestyle-interventions/32670/Tune in to hear experts discuss the unique challenges and considerations in managing multiple sclerosis in older adults.Addressing Barriers to Early Detection for Alzheimer's Disease
https://reachmd.com/programs/alzheimers-disease-towards-early-detection/addressing-barriers-early-detection-alzheimers-disease/8322/Dr. Marwan Sabbagh from the Barrow Neurological Institute discusses barriers to early detection for Alzheimer's and how to address them in practice.Recognizing Alzheimer's Disease at the Earliest Stages: Key Signs and Symptoms
https://reachmd.com/programs/alzheimers-disease-towards-early-detection/recognizing-alzheimers-disease-earliest-stages-key-signs-and-symptoms/8319/Dr. Howard Fillit from the Alzheimer's Drug Discovery Foundation discusses keys to early recognition for Alzheimer's disease.Understanding Crossover and Endpoints in ASCENT-03 and -04
https://reachmd.com/programs/project-oncology/crossover-endpoints-ascent-03-04/48951/Knowing how crossover affects efficacy endpoints is key in interpreting clinical trial data for metastatic triple-negative breast cancer. The ASCENT-03 and -04 trials, which allowed crossover and tested sacituzumab govitecan in the first-line setting, offer insights into the limitations of overall sObesity and Cancer Screening: National Trends and Disparities Revealed
https://reachmd.com/programs/clinicians-roundtable/obesity-and-cancer-screening-national-trends-and-disparities-revealed/39649/Emerging data reveal a troubling trend: individuals with higher body mass index are significantly less likely to receive routine cancer screenings, raising urgent concerns about care equity. Join Dr. Vance Albaugh, Assistant Professor of Metabolic Surgery at Pennington Biomedical Research CenterExploring Common Barriers in Pediatric Atopic Dermatitis Management
https://reachmd.com/programs/dermconsult/exploring-common-barriers-in-pediatric-atopic-dermatitis-management/36442/Even though there are a lot of treatment options available for pediatric atopic dermatitis, family concerns about safety and access play a big role in management. Tune in to hear Dr. Nicole Harter, Associate Professor in the Department of Dermatology and the Pediatric Dermatology Fellowship ProgramAre Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
https://reachmd.com/programs/project-oncology/are-subcutaneous-immunotherapies-expanding-access-and-efficiency-in-cancer-care/36401/Subcutaneous immunotherapies are emerging as a promising alternative to traditional IV delivery for immune checkpoint inhibitors, demonstrating comparable safety and efficacy along with meaningful time savings. But reimbursement gaps, dosing complexities, and biosimilar competition present challengeLessons from COVID: The Ripple Effect on Immunity
https://reachmd.com/programs/what-your-patients-are-talking-about/lessons-from-covid-the-ripple-effect-on-immunity/15489/Here’s how lifesaving measures used during the COVID-19 pandemic affected the immune system’s ability to fend off other illnesses.